Tobira Therapeutics Announces Date of 2016 Second Quarter Financial Results and CENTAUR Study Update Conference Call
August 01, 2016 08:00 ET
|
Tobira Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 1, 2016 (GLOBE NEWSWIRE) -- Tobira Therapeutics, Inc. (NASDAQ:TBRA), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies...
Tobira Therapeutics Announces Date of 2016 First Quarter Financial Results and Conference Call
May 02, 2016 09:15 ET
|
Tobira Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., May 2, 2016 (GLOBE NEWSWIRE) -- Tobira Therapeutics, Inc. (NASDAQ:TBRA), a clinical-stage biopharmaceutical company focused on the development and commercialization of...
Tobira Therapeutics Announces Date of 2015 Fourth Quarter Financial Results and Conference Call
February 22, 2016 16:05 ET
|
Tobira Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 22, 2016 (GLOBE NEWSWIRE) -- Tobira Therapeutics, Inc. (NASDAQ:TBRA), a biopharmaceutical company developing novel treatments for nonalcoholic steatohepatitis (NASH),...
Tobira Therapeutics Announces Date of 2015 Third Quarter Financial Results and Conference Call
November 03, 2015 08:00 ET
|
Tobira Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 3, 2015 (GLOBE NEWSWIRE) -- Tobira Therapeutics, Inc. (NASDAQ:TBRA), a biopharmaceutical company developing novel treatments for nonalcoholic steatohepatitis (NASH),...